Stock listing

A1KAGC Stock Price, News, Filings & Events — Coloplast A/s Class B

Selected listing: A1KAGC · LS · EUR · DE

This page tracks Coloplast A/s Class B's A1KAGC:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A1KAGC:LS. A1KAGC:LS is the stock-level entry point for investors researching Coloplast A/s Class B, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Coloplast A/S Class B is a public company based in Denmark, specializing in medical devices and services. The company has a market capitalization of approximately 14.22 billion USD. Coloplast focuses on developing innovative solutions for individuals with intimate healthcare needs.

A1KAGC:LSEURDEUpdated August 22, 2026
Coloplast A/s Class B logo
Ticker
A1KAGC:LS
Asset type
Stock
Market cap
$15.28B
Sector
Health Technology
Industry
Medical Specialties
Exchange
LS
Currency
EUR

Coloplast A/s Class B A1KAGC:LS stock context

This page tracks Coloplast A/s Class B's A1KAGC:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A1KAGC:LS. A1KAGC:LS is the stock-level entry point for investors researching Coloplast A/s Class B, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Coloplast A/S Class B is a public company based in Denmark, specializing in medical devices and services. The company has a market capitalization of approximately 14.22 billion USD. Coloplast focuses on developing innovative solutions for individuals with intimate healthcare needs.

Latest news from Coloplast A/s Class B

All Coloplast A/s Class B news →

Coloplast A/s Class B earnings calls

Research Coloplast A/s Class B

Alternate listings